Canon Medical Systems USA announced Monday, Oct. 21, that the Advanced Intelligent Clear-IQ Engine (AiCE) for its ultra-high resolution CT scanner has gained FDA approval.
The company’s Aquilion Precision scanner first received FDA approval back in April 2018. With AiCE now approved, according to Canon, Aquilion Precision will be able to perform “super-high resolution studies at doses equivalent to standard resolution CT” thanks to a deep learning algorithm that can provide improved image reconstruction.
“As we strive for precision medicine, we realize the importance of starting with the foundation of a precise diagnosis,” Tim Nicholson, acting manager director of Canon Medical Systems USA’s CT business unit, said in a prepared statement. “Canon Medical is committed to developing intelligent solutions that help providers generate clearer, more holistic images to help achieve better outcomes, without increasing dose. This technology represents a new era in image reconstruction, which may help provide more possibilities in improving patient care than ever before.”
The AiCE is also now available on the company’s Aquilion ONE/GENESIS Edition CT system.